Michael Davidson to United States Food and Drug Administration
This is a "connection" page, showing publications Michael Davidson has written about United States Food and Drug Administration.
Connection Strength
0.213
-
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther. 2008 Mar; 6(3):391-409.
Score: 0.065
-
Statin safety: an appraisal from the adverse event reporting system. Am J Cardiol. 2006 Apr 17; 97(8A):32C-43C.
Score: 0.056
-
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Am J Cardiol. 2005 Jan 01; 95(1):120-2.
Score: 0.052
-
What kinds of data should be available to probe the effects of nutrients, food supplements or vitamins on serum lipoprotein levels and/or atherosclerosis? Am J Cardiol. 1998 Apr 23; 81(8A):80F-83F.
Score: 0.033
-
Panel discussion: what is the future of macronutrient substitutes in North America? Regul Toxicol Pharmacol. 1996 Feb; 23(1 Pt 2):S51-9.
Score: 0.007